BICYCLE THERAPEUTICS PLC Financial Ratios
BCYC|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 0.98 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
- Currently unprofitable: Net income is negative
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-35.9%
Profit Margin
-301.7%
Net Income / Revenue
Asset Turnover
0.10
Revenue / Total Assets
Equity Multiplier
1.18
Total Assets / Equity
Composite: -35.9% (reported: -35.9%)
Profitability
Liquidity
Current Ratio
11.98
Quick Ratio
11.98
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.10
Inventory Turnover
-
Days Sales Outstanding
0 days
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026
Earnings Quality
Accrual Ratio
+3.7%
+4.1pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.